Rights and permissions
About this article
Cite this article
UK NICE rosiglitazone guidance should be amended. Pharmacoecon. Outcomes News 312, 3 (2001). https://doi.org/10.1007/BF03269313
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269313